Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash Flows From Operating Activities
Loss from continuing operations	$ (47,443)	$ (36,552)
Loss from discontinued operations	(19,147)	(3,722)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	13,920	16,521
Impairment of indefinite lived intangible asset	12,200
Share-based compensation	4,051	4,556
Accretion of interest on long-term debt	2,099	1,597
Provision for (recovery of) bad debt	(373)	1,342
Provision for write-down of inventories	408	1,020
Loss on disposal of property and equipment	391	166
Gain on previously held equity interest in Morphormics	(662)
Loss from deconsolidation of a variable interest entity	3,442
Changes in assets and liabilities:
Restricted cash	(1,050)	(335)
Accounts receivable	5,415	(15,036)
Inventories	(7,308)	12,104
Prepaid expenses and other assets	2,096	7,703
Deferred cost of revenue	(2,951)	(1,751)
Accounts payable	3,335	(16,974)
Accrued liabilities	(13,871)	(23,800)
Customer advances	49	(2,460)
Deferred revenue	3,588	17,204
Net cash used in operating activities	(41,811)	(38,417)
Cash Flows From Investing Activities
Purchases of property and equipment, net	(9,207)	(3,900)
Purchase of intangible asset	(232)
Acquisition of business, net of cash acquired	(3,861)	(1,384)
Net cash used in investing activities	(13,300)	(5,284)
Cash Flows From Financing Activities
Proceeds from issuance of common stock	5,147	2,030
Proceeds from debt, net of costs		96,100
Net cash provided by financing activities	5,147	98,130
Effect of exchange rate changes on cash and cash equivalents	1,233	(1,868)
Net increase (decrease) in cash and cash equivalents	(48,731)	52,561
Cash and cash equivalents at beginning of period	143,504	95,906
Cash and cash equivalents at end of period	$ 94,773	$ 148,467